ARCHIVES

Investigators Testing Ways To Overcome Gleevec Resistance: High Dose, New Drugs

This article is from The Cancer Letter archive.

Vol. 28 No. 1 | January 28, 2005

Download PDF Visit The Full Archive

Related Articles

Statistics Review Shows Improved Mortality Under 65, Through 1986

January 19, 1990

NCI Programs: HMO Research Network wins $16 Million Grant for Prevention Studies

July 30, 1999

Health Care Delivery: Value Of Informatics To PPMs Is a Message for Academic Centers

November 22, 1996

ASCO Awards Contract For D.C. Office

January 5, 1990

Two Phase II Ibrutinib Studies Presented to EHA Demonstrate Efficacy as a Monotherapy

July 26, 2013

Appeals Court Finds Terminally Ill Patients Have Constitutional Right To Phase I Drugs.

May 5, 2006